Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2012, Article ID 740353, 9 pages
http://dx.doi.org/10.1155/2012/740353
Research Article

PKC and ER Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients

1Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 S. Wood Street, Chicago, IL 60612, USA
2Design and Analysis Core, Center for Clinical and Translational Science, University of Illinois, 914 S. Wood Street, Chicago, IL 60612, USA
3Department of Pathology, Rush University Medical Center, 1643 W. Congress Parkway, Murdock Building, Street 593, Chicago, IL 60612, USA

Received 22 July 2011; Accepted 18 December 2011

Academic Editor: Thelma Hurd

Copyright © 2012 Debra A. Tonetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Frank S. Ong, Kingshuk Das, Jay Wang, Hana Vakil, Jane Z. Kuo, Wendell-Lamar B. Blackwell, Stephen W. Lim, Mark O. Goodarzi, Kenneth E. Bernstein, Jerome I. Rotter, and Wayne W. Grody, “Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing,” Expert Review Of Molecular Diagnostics, vol. 12, no. 6, pp. 593–602, 2012. View at Publisher · View at Google Scholar
  • David P. Rose, and Linda Vona-Davis, “Biochemical and molecular mechanisms for the association between obesity, chronic Inflammation, and breast cancer,” BioFactors, vol. 40, no. 1, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Bethany Perez White, Mary Ellen Molloy, Huiping Zhao, Yiyun Zhang, and Debra A. Tonetti, “Extranuclear ER alpha is associated with regression of T47D PKC alpha-overexpressing, tamoxifen-resistant breast cancer,” Molecular Cancer, vol. 12, 2013. View at Publisher · View at Google Scholar
  • R Garg, L G Benedetti, M B Abera, H Wang, M Abba, and M G Kazanietz, “Protein kinase C and cancer: what we know and what we do not,” Oncogene, 2013. View at Publisher · View at Google Scholar
  • B. Humphries, Z. Wang, A. L. Oom, T. Fisher, D. Tan, Y. Cui, Y. Jiang, and C. Yang, “MicroRNA-200b targets protein kinase C  and suppresses triple-negative breast cancer metastasis,” Carcinogenesis, 2014. View at Publisher · View at Google Scholar
  • Tameka A. Bailey, Haitao Luan, Eric Tom, Timothy Alan Bielecki, Bhopal Mohapatra, Gulzar Ahmad, Manju George, David L. Kelly, Amarnath Natarajan, Srikumar M. Raja, Vimla Band, and Hamid Band, “A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells,” Journal of Biological Chemistry, vol. 289, no. 44, pp. 30443–30458, 2014. View at Publisher · View at Google Scholar
  • Jordan M. Reese, Vera J. Suman, Malayannan Subramaniam, Xianglin Wu, Vivian Negron, Anne Gingery, Kevin S. Pitel, Sejal S. Shah, Heather E. Cunliffe, Ann E. McCullough, Barbara A. Pockaj, Fergus J. Couch, Janet E. Olson, Carol Reynolds, Wilma L. Lingle, Thomas C. Spelsberg, Matthew P. Goetz, James N. Ingle, and John R. Hawse, “ER beta 1: characterization, prognosis, and evaluation of treatment strategies in ER alpha-positive and -negative breast cancer,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Jeong-Hun Kang, “Protein Kinase C (PKC) Isozymes and Cancer,” New Journal of Science, vol. 2014, pp. 1–36, 2014. View at Publisher · View at Google Scholar
  • Chia-Herng Yue, Liang-Chih Liu, Erl-Shyh Kao, Ho Lin, Li-Sung Hsu, Chih-Wei Hsu, Yu-Yu Lin, Yi-Syuan Lin, Jer-Yuh Liu, and Chia-Jen Lee, “Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells,” Molecular Medicine Reports, vol. 14, no. 2, pp. 1636–1642, 2016. View at Publisher · View at Google Scholar
  • Wanjun Lin, Jiajun Huang, Zhongwen Yuan, Senling Feng, Ying Xie, and Wenzhe Ma, “Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Thao N. D. Pham, Bethany E. Perez White, Huiping Zhao, Fariborz Mortazavi, and Debra A. Tonetti, “Protein kinase C α enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin,” BMC Cancer, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar